1887

Abstract

Cytosine-guanosinedeoxynucleotide (CpG) DNA can be used for the stimulation of the toll-like receptor (TLR)21 signalling pathway in avian species which ultimately leads to up-regulation of gene transcription for pro-inflammatory molecules including nitric oxide and recruitment of innate immune cells. The objective of this study was to determine the antiviral effect of NO, produced in response to in ovo delivery of CpG DNA, against avian influenza virus (AIV) infection. We found that when CpG DNA is delivered at embryo day (ED)18 in ovo and subsequently challenged with H4N6 AIV at ED19 pre-hatch and day 1 post-hatching, CpG DNA reduces H4N6 AIV replication associated with enhanced NO production and macrophage recruitment in lungs. In vitro, we showed that NO originating from macrophages is capable of eliciting an antiviral response against H4N6 AIV infection. This study provides insights into the mechanisms of CpG DNA-mediated antiviral response, particularly against AIV infection in avian species.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.000787
2017-06-14
2019-10-20
Loading full text...

Full text loading...

/deliver/fulltext/jgv/98/6/1209.html?itemId=/content/journal/jgv/10.1099/jgv.0.000787&mimeType=html&fmt=ahah

References

  1. Cardona CJ, Xing Z, Sandrock CE, Davis CE. Avian influenza in birds and mammals. Comp Immunol Microbiol Infect Dis 2009;32:255–273 [CrossRef][PubMed]
    [Google Scholar]
  2. Mänz B, Schwemmle M, Brunotte L. Adaptation of avian influenza A virus polymerase in mammals to overcome the host species barrier. J Virol 2013;87:7200–7209 [CrossRef][PubMed]
    [Google Scholar]
  3. Lee CW, Senne DA, Suarez DL. Effect of vaccine use in the evolution of Mexican lineage H5N2 avian influenza virus. J Virol 2004;78:8372–8381 [CrossRef][PubMed]
    [Google Scholar]
  4. Iannacone M, Moseman EA, Tonti E, Bosurgi L, Junt T et al. Subcapsular sinus macrophages prevent CNS invasion on peripheral infection with a neurotropic virus. Nature 2010;465:1079–1083 [CrossRef][PubMed]
    [Google Scholar]
  5. Gordon S. Pattern recognition receptors: doubling up for the innate immune response. Cell 2002;111:927–930[PubMed][CrossRef]
    [Google Scholar]
  6. Medzhitov R, Janeway CA Jr. Innate immunity: the virtues of a nonclonal system of recognition. Cell 1997;91:295–298 [CrossRef][PubMed]
    [Google Scholar]
  7. Krieg AM. Antitumor applications of stimulating toll-like receptor 9 with CpG oligodeoxynucleotides. Curr Oncol Rep 2004;6:88–95 [CrossRef][PubMed]
    [Google Scholar]
  8. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000;408:740–745 [CrossRef][PubMed]
    [Google Scholar]
  9. Gupta GK, Agrawal DK. CpG oligodeoxynucleotides as TLR9 agonists: therapeutic application in allergy and asthma. BioDrugs 2010;24:225–235 [CrossRef][PubMed]
    [Google Scholar]
  10. Dar A, Potter A, Tikoo S, Gerdts V, Lai K et al. CpG oligodeoxynucleotides activate innate immune response that suppresses infectious bronchitis virus replication in chicken embryos. Avian Dis 2009;53:261–267 [CrossRef][PubMed]
    [Google Scholar]
  11. Roh HJ, Sung HW, Kwon HM. Effects of DDA, CpG-ODN, and plasmid-encoded chicken IFN-γ on protective immunity by a DNA vaccine against IBDV in chickens. J Vet Sci 2006;7:361–368 [CrossRef][PubMed]
    [Google Scholar]
  12. Xie H, Raybourne RB, Babu US, Lillehoj HS, Heckert RA. CpG-induced immunomodulation and intracellular bacterial killing in a chicken macrophage cell line. Dev Comp Immunol 2003;27:823–834 [CrossRef][PubMed]
    [Google Scholar]
  13. Andersen JM, Al-Khairy D, Ingalls RR. Innate immunity at the mucosal surface: role of toll-like receptor 3 and toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens. Biol Reprod 2006;74:824–831 [CrossRef][PubMed]
    [Google Scholar]
  14. Thapa S, Cader MS, Murugananthan K, Nagy E, Sharif S et al. In ovo delivery of CpG DNA reduces avian infectious laryngotracheitis virus induced mortality and morbidity. Viruses 2015;7:1832–1852 [CrossRef][PubMed]
    [Google Scholar]
  15. Gomis S, Babiuk L, Godson DL, Allan B, Thrush T et al. Protection of chickens against Escherichia coli infections by DNA containing CpG motifs. Infect Immun 2003;71:857–863 [CrossRef][PubMed]
    [Google Scholar]
  16. Li X, Liu D, Liu X, Jiang W, Zhou W et al. CpG ODN107 potentiates radiosensitivity of human glioma cells via TLR9-mediated NF-κB activation and NO production. Tumour Biol 2012;33:1607–1618 [CrossRef][PubMed]
    [Google Scholar]
  17. Bi Z, Reiss CS. Inhibition of vesicular stomatitis virus infection by nitric oxide. J Virol 1995;69:2208–2213[PubMed]
    [Google Scholar]
  18. Croen KD. Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication. J Clin Invest 1993;91:2446–2452 [CrossRef][PubMed]
    [Google Scholar]
  19. Saura M, Zaragoza C, Mcmillan A, Quick RA, Hohenadl C et al. An antiviral mechanism of nitric oxide: inhibition of a viral protease. Immunity 1999;10:21–28[PubMed][CrossRef]
    [Google Scholar]
  20. Olishevsky S, Burlaka A, Sidorik E, Shlyakhovenko V, Garpenko Y et al. Modulation of ROS/NO production by murine peritoneal macrophages in response to bacterial CpG DNA stimulation. Exp Oncol 2006;28:114–120[PubMed]
    [Google Scholar]
  21. Utaisincharoen P, Anuntagool N, Chaisuriya P, Pichyangkul S, Sirisinha S. CpG ODN activates NO and iNOS production in mouse macrophage cell line (RAW 264.7). Clin Exp Immunol 2002;128:467–473 [CrossRef][PubMed]
    [Google Scholar]
  22. He H, Mackinnon KM, Genovese KJ, Kogut MH. CpG oligodeoxynucleotide and double-stranded RNA synergize to enhance nitric oxide production and mRNA expression of inducible nitric oxide synthase, pro-inflammatory cytokines and chemokines in chicken monocytes. Innate Immun 2011;17:137–144 [CrossRef][PubMed]
    [Google Scholar]
  23. He H, Genovese KJ, Nisbet DJ, Kogut MH. Synergy of CpG oligodeoxynucleotide and double-stranded RNA (poly I:C) on nitric oxide induction in chicken peripheral blood monocytes. Mol Immunol 2007;44:3234–3242 [CrossRef][PubMed]
    [Google Scholar]
  24. He H, Genovese KJ, Lowry VK, Nisbet DJ, Kogut MH. Response of nitric oxide production to CpG oligodeoxynucleotides in turkey and chicken peripheral blood monocytes. FEMS Immunol Med Microbiol 2006;48:99–106 [CrossRef][PubMed]
    [Google Scholar]
  25. Sharma JM, Burmester BR. Resistance to Marek's disease at hatching in chickens vaccinated as embryos with the turkey herpesvirus. Avian Dis 1982;26:134–139 [CrossRef][PubMed]
    [Google Scholar]
  26. Abdul-Careem MF. Main Challenges in Poultry Farming: Hatchery Vaccination Zaragoza, Spain: Group Asis Biomedia; 2015
    [Google Scholar]
  27. Thapa S, Nagy E, Abdul-Careem MF. In ovo delivery of Toll-like receptor 2 ligand, lipoteichoic acid induces pro-inflammatory mediators reducing post-hatch infectious laryngotracheitis virus infection. Vet Immunol Immunopathol 2015;164:170–178 [CrossRef][PubMed]
    [Google Scholar]
  28. Gomis S, Babiuk L, Allan B, Willson P, Waters E et al. Protection of neonatal chicks against a lethal challenge of Escherichia coli using DNA containing cytosine-phosphodiester-guanine motifs. Avian Dis 2004;48:813–822 [CrossRef][PubMed]
    [Google Scholar]
  29. Taghavi A, Allan B, Mutwiri G, van Kessel A, Willson P et al. Protection of neonatal broiler chicks against Salmonella Typhimurium septicemia by DNA containing CpG motifs. Avian Dis 2008;52:398–406 [CrossRef][PubMed]
    [Google Scholar]
  30. Mallick AI, Kulkarni RR, St Paul M, Parvizi P, Nagy E et al. Vaccination with CpG-adjuvanted avian influenza virosomes promotes antiviral immune responses and reduces virus shedding in chickens. Viral Immunol 2012;25:226–231 [CrossRef][PubMed]
    [Google Scholar]
  31. Singh SM, Alkie TN, Hodgins DC, Nagy É, Shojadoost B et al. Systemic immune responses to an inactivated, whole H9N2 avian influenza virus vaccine using class B CpG oligonucleotides in chickens. Vaccine 2015;33:3947–3952 [CrossRef][PubMed]
    [Google Scholar]
  32. Mallick AI, Parvizi P, Read LR, Nagy E, Behboudi S et al. Enhancement of immunogenicity of a virosome-based avian influenza vaccine in chickens by incorporating CpG-ODN. Vaccine 2011;29:1657–1665 [CrossRef][PubMed]
    [Google Scholar]
  33. Abdul-Careem MF, Firoz Mian M, Gillgrass AE, Chenoweth MJ, Barra NG et al. FimH, a TLR4 ligand, induces innate antiviral responses in the lung leading to protection against lethal influenza infection in mice. Antiviral Res 2011;92:346–355 [CrossRef][PubMed]
    [Google Scholar]
  34. Szabó C, Southan GJ, Thiemermann C. Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci USA 1994;91:12472–12476 [CrossRef][PubMed]
    [Google Scholar]
  35. Wildhirt SM, Suzuki H, Wolf WP, Dudek R, Horstman D et al. S-Methylisothiourea inhibits inducible nitric oxide synthase and improves left ventricular performance after acute myocardial infarction. Biochem Biophys Res Commun 1996;227:328–333 [CrossRef][PubMed]
    [Google Scholar]
  36. Xing Z, Schat KA. Inhibitory effects of nitric oxide and gamma interferon on in vitro and in vivo replication of Marek's disease virus. J Virol 2000;74:3605–3612 [CrossRef][PubMed]
    [Google Scholar]
  37. Olbrich AR, Schimmer S, Heeg K, Schepers K, Schumacher TN et al. Effective postexposure treatment of retrovirus-induced disease with immunostimulatory DNA containing CpG motifs. J Virol 2002;76:11397–11404 [CrossRef][PubMed]
    [Google Scholar]
  38. Pyles RB, Higgins D, Chalk C, Zalar A, Eiden J et al. Use of immunostimulatory sequence-containing oligonucleotides as topical therapy for genital herpes simplex virus type 2 infection. J Virol 2002;76:11387–11396 [CrossRef][PubMed]
    [Google Scholar]
  39. Iversen AC, Steinkjer B, Nilsen N, Bohnhorst J, Moen SH et al. A proviral role for CpG in cytomegalovirus infection. J Immunol 2009;182:5672–5681 [CrossRef][PubMed]
    [Google Scholar]
  40. Mchutchison JG, Bacon BR, Gordon SC, Lawitz E, Shiffman M et al. Phase 1B, randomized, double-blind, dose-escalation trial of CPG 10101 in patients with chronic hepatitis C virus. Hepatology 2007;46:1341–1349 [CrossRef][PubMed]
    [Google Scholar]
  41. Isogawa M, Robek MD, Furuichi Y, Chisari FV. Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. J Virol 2005;79:7269–7272 [CrossRef][PubMed]
    [Google Scholar]
  42. Barjesteh N, Behboudi S, Brisbin JT, Villanueva AI, Nagy E et al. TLR ligands induce antiviral responses in chicken macrophages. PLoS One 2014;9:e105713 [CrossRef][PubMed]
    [Google Scholar]
  43. Rimmelzwaan GF, Baars MM, de Lijster P, Fouchier RA, Osterhaus AD. Inhibition of influenza virus replication by nitric oxide. J Virol 1999;73:8880–8883[PubMed]
    [Google Scholar]
  44. Regev-Shoshani G, Vimalanathan S, Mcmullin B, Road J, Av-Gay Y et al. Gaseous nitric oxide reduces influenza infectivity in vitro. Nitric Oxide 2013;31:48–53 [CrossRef][PubMed]
    [Google Scholar]
  45. Haddadi S, Kim DS, Jasmine H, van der Meer F, Czub M et al. Induction of Toll-like receptor 4 signaling in avian macrophages inhibits infectious laryngotracheitis virus replication in a nitric oxide dependent way. Vet Immunol Immunopathol 2013;155:270–275 [CrossRef][PubMed]
    [Google Scholar]
  46. Flodström M, Horwitz MS, Maday A, Balakrishna D, Rodriguez E et al. A critical role for inducible nitric oxide synthase in host survival following coxsackievirus B4 infection. Virology 2001;281:205–215 [CrossRef][PubMed]
    [Google Scholar]
  47. Zell R, Markgraf R, Schmidtke M, Görlach M, Stelzner A et al. Nitric oxide donors inhibit the coxsackievirus B3 proteinases 2A and 3C in vitro, virus production in cells, and signs of myocarditis in virus-infected mice. Med Microbiol Immunol 2004;193:91–100 [CrossRef][PubMed]
    [Google Scholar]
  48. Kreil TR, Eibl MM. Nitric oxide and viral infection: NO antiviral activity against a flavivirus in vitro, and evidence for contribution to pathogenesis in experimental infection in vivo. Virology 1996;219:304–306 [CrossRef][PubMed]
    [Google Scholar]
  49. Klingström J, Akerström S, Hardestam J, Stoltz M, Simon M et al. Nitric oxide and peroxynitrite have different antiviral effects against hantavirus replication and free mature virions. Eur J Immunol 2006;36:2649–2657 [CrossRef][PubMed]
    [Google Scholar]
  50. He H, Crippen TL, Farnell MB, Kogut MH. Identification of CpG oligodeoxynucleotide motifs that stimulate nitric oxide and cytokine production in avian macrophage and peripheral blood mononuclear cells. Dev Comp Immunol 2003;27:621–627 [CrossRef][PubMed]
    [Google Scholar]
  51. Liu X, Srinivasan P, Collard E, Grajdeanu P, Zweier JL et al. Nitric oxide diffusion rate is reduced in the aortic wall. Biophys J 2008;94:1880–1889 [CrossRef][PubMed]
    [Google Scholar]
  52. Colasanti M, Persichini T, Venturini G, Ascenzi P. S-nitrosylation of viral proteins: molecular bases for antiviral effect of nitric oxide. IUBMB Life 1999;48:25–31 [CrossRef][PubMed]
    [Google Scholar]
  53. Nguyen T, Brunson D, Crespi CL, Penman BW, Wishnok JS et al. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc Natl Acad Sci USA 1992;89:3030–3034 [CrossRef][PubMed]
    [Google Scholar]
  54. Wink DA, Kasprzak KS, Maragos CM, Elespuru RK, Misra M et al. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 1991;254:1001–1003 [CrossRef][PubMed]
    [Google Scholar]
  55. Sharpe MA, Ollosson R, Stewart VC, Clark JB. Oxidation of nitric oxide by oxomanganese–salen complexes: a new mechanism for cellular protection by superoxide dismutase/catalase mimetics. Biochem J 2002;366:97–107 [CrossRef][PubMed]
    [Google Scholar]
  56. Sekkaï D, Aillet F, Israël N, Lepoivre M. Inhibition of NF-κB and HIV-1 long terminal repeat transcriptional activation by inducible nitric oxide synthase 2 activity. J Biol Chem 1998;273:3895–3900 [CrossRef][PubMed]
    [Google Scholar]
  57. Yi AK, Tuetken R, Redford T, Waldschmidt M, Kirsch J et al. CpG motifs in bacterial DNA activate leukocytes through the pH-dependent generation of reactive oxygen species. J Immunol 1998;160:4755–4761[PubMed]
    [Google Scholar]
  58. de Geus ED, Jansen CA, Vervelde L. Uptake of particulate antigens in a nonmammalian lung: phenotypic and functional characterization of avian respiratory phagocytes using bacterial or viral antigens. J Immunol 2012;188:4516–4526 [CrossRef][PubMed]
    [Google Scholar]
  59. Lavric M, Bencina D, Kothlow S, Kaspers B, Narat M. Mycoplasma synoviae lipoprotein MSPB, the N-terminal part of VlhA haemagglutinin, induces secretion of nitric oxide, IL-6 and IL-1β in chicken macrophages. Vet Microbiol 2007;121:278–287 [CrossRef][PubMed]
    [Google Scholar]
  60. Robinson CM, O'Dee D, Hamilton T, Nau GJ. Cytokines involved in interferon-gamma production by human macrophages. J Innate Immun 2010;2:56–65 [CrossRef][PubMed]
    [Google Scholar]
  61. Setta A, Barrow PA, Kaiser P, Jones MA. Immune dynamics following infection of avian macrophages and epithelial cells with typhoidal and non-typhoidal Salmonella enterica serovars; bacterial invasion and persistence, nitric oxide and oxygen production, differential host gene expression, NF-κB signalling and cell cytotoxicity. Vet Immunol Immunopathol 2012;146:212–224 [CrossRef][PubMed]
    [Google Scholar]
  62. Pertile TL, Karaca K, Sharma JM, Walser MM. An antiviral effect of nitric oxide: inhibition of reovirus replication. Avian Dis 1996;40:342–348 [CrossRef][PubMed]
    [Google Scholar]
  63. Bhat A, Gomis S, Potter A, Tikoo SK. Role of Hsp90 in CpG ODN mediated immunostimulation in avian macrophages. Mol Immunol 2010;47:1337–1346 [CrossRef][PubMed]
    [Google Scholar]
  64. Qureshi MA, Miller L, Lillehoj HS, Ficken MD. Establishment and characterization of a chicken mononuclear cell line. Vet Immunol Immunopathol 1990;26:237–250 [CrossRef][PubMed]
    [Google Scholar]
  65. Dil N, Qureshi MA. Involvement of lipopolysaccharide related receptors and nuclear factor κB in differential expression of inducible nitric oxide synthase in chicken macrophages from different genetic backgrounds. Vet Immunol Immunopathol 2002;88:149–161 [CrossRef][PubMed]
    [Google Scholar]
  66. Dil N, Qureshi MA. Differential expression of inducible nitric oxide synthase is associated with differential Toll-like receptor-4 expression in chicken macrophages from different genetic backgrounds. Vet Immunol Immunopathol 2002;84:191–207 [CrossRef][PubMed]
    [Google Scholar]
  67. Hussain I, Qureshi MA. Nitric oxide synthase activity and mRNA expression in chicken macrophages. Poult Sci 1997;76:1524–1530 [CrossRef][PubMed]
    [Google Scholar]
  68. Wakenell PS, Bryan T, Schaeffer J, Avakian A, Williams C et al. Effect of in ovo vaccine delivery route on herpesvirus of turkeys/SB-1 efficacy and viremia. Avian Dis 2002;46:274–280 [CrossRef][PubMed]
    [Google Scholar]
  69. Guo ZY, Giambrone JJ, Wu H, Dormitorio T. Safety and efficacy of an experimental reovirus vaccine for in ovo administration. Avian Dis 2003;47:1423–1428 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.000787
Loading
/content/journal/jgv/10.1099/jgv.0.000787
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error